jieduquyuziyin

contains root of Rehmannia glutinosa, carapace of Trionyx sinensis Wiegmann, dried aerial parts of Artemisia annua L., rhizome of Cimicifuga heracleifolia Kom., dried aerial parts of Hedyotis diffusa Willd., root of Paeonia veitchii Lynch., dried aerial parts of Centella asiatica, seed of Coix lacryma-jobi L. var. mayuen, fruit of Citrus medica Linn., and rhizome of Glycyrrhiza uralensis; for treatment of Lupus Erythematosus,

Also Known As:

Networked: 13 relevant articles (3 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Fan, Xuemin: 3 articles (01/2022 - 01/2019)
2.	Fan, Yongsheng: 3 articles (01/2022 - 01/2014)
3.	Ji, Lina: 3 articles (01/2022 - 01/2019)
4.	Wen, Chengping: 3 articles (01/2022 - 01/2014)
5.	Ding, Xinghong: 3 articles (02/2018 - 01/2014)
6.	Bao, Jie: 2 articles (01/2022 - 01/2020)
7.	Hou, Xiaoli: 2 articles (01/2020 - 01/2019)
8.	Li, Rongqun: 2 articles (01/2020 - 01/2019)
9.	Zhuang, Aiwen: 2 articles (01/2020 - 01/2019)
10.	Yao, Li: 2 articles (01/2014 - 11/2013)

Related Diseases

1.	Systemic Lupus Erythematosus (Libman-Sacks Disease) 07/01/2015 - "Jieduquyuziyin prescription (JP) is a traditional Chinese medicinal (TCM) formula which has been demonstrated to be effective for systemic lupus erythematosus (SLE) treatment as an approved hospital prescription for many years in China. " 01/01/2014 - "Rapid resolution liquid chromatography coupled with quadrupole time-of-flight mass spectrometry-based metabolomics approach to study the effects of jieduquyuziyin prescription on systemic lupus erythematosus." 11/01/2013 - "[Study on intervention effect of Jieduquyuziyin prescription systemic lupus erythematosus by HPLC-Q-TOF/MS]." 01/01/2020 - "Jieduquyuziyin prescription (JP) has been used to treat systemic lupus erythematosus (SLE). " 02/01/2018 - "Exploring the mechanism of Jieduquyuziyin prescription on systemic lupus erythematosus by GC-MS-based urine metabolomics."
2.	Lupus Nephritis 01/01/2022 - "Jieduquyuziyin prescription (JP) has been used to treat lupus nephritis (LN) and its effectiveness in the treatment of LN has been clinically proven, but the underlying mechanisms have yet to be completely understood. " 01/01/2022 - "Investigating the Mechanisms of Jieduquyuziyin Prescription Improves Lupus Nephritis and Fibrosis via FXR in MRL/lpr Mice." 11/15/2022 - "The Jieduquyuziyin prescription (JP), a traditional Chinese medicine (TCM) formula, has been used as an approved hospital prescription to improve the efficacy of prednisone (Pred) in systemic lupus erythematosus (SLE) and lupus nephritis (LN) treatment. "
3.	Autoimmune Diseases (Autoimmune Disease) 01/01/2019 - "Systemic lupus erythematosus (SLE) is a chronic autoimmune disease, and Jieduquyuziyin prescription (JP) is a traditional Chinese medicine (TCM) formula that has been testified to be effective for SLE treatment as an approved hospital prescription for many years in China. "
4.	Atherosclerosis 01/10/2024 - "Corrigendum to "Jieduquyuziyin prescription alleviates SLE complicated by atherosclerosis via promoting cholesterol efflux and suppressing TLR9/MyD88 activation" [J. " 06/12/2023 - "Jieduquyuziyin prescription alleviates SLE complicated by atherosclerosis via promoting cholesterol efflux and suppressing TLR9/MyD88 activation."
5.	Inflammation (Inflammations) 01/01/2022 - "Jieduquyuziyin prescription is a famous prescription with immune modulating and inflammation controlling effects, which is efficacious in the treatment of SLE. "

Related Drugs and Biologics

1.	Prednisone (Sone)
2.	prednylidene (Pred)
3.	Cholesterol
4.	Therapeutic Uses

Related Therapies and Procedures

1.	Chinese Traditional Medicine (Traditional Chinese Medicine)
2.	Aftercare (After-Treatment)